ACQUIRED HEMOPHILIA A FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Mitani, Yuichi [1 ]
Arakawa, Yuki [1 ]
Mori, Makiko [1 ]
Fukuoka, Kohei [1 ]
Oshima, Koichi [1 ]
Niitsu, Takehiro [2 ]
Kawashima, Hiroshi [3 ]
Fujinaga, Shuichiro [4 ]
Koh, Katsuyoshi [1 ]
机构：
[1] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan
[2] Saitama Childrens Med Ctr, Dept Crit Care Med, Saitama, Japan
[3] Saitama Childrens Med Ctr, Dept Pediat Surg, Saitama, Japan
[4] Saitama Childrens Med Ctr, Div Nephrol, Saitama, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS11-3
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation
    Trahair, T. N.
    Vowels, M. R.
    Johnston, K.
    Cohn, R. J.
    Russell, S. J.
    Neville, K. A.
    Carroll, S.
    Marshall, G. M.
    BONE MARROW TRANSPLANTATION, 2007, 40 (08) : 741 - 746
  • [22] Autologous stem cell transplantation in patients with high-risk plasmacytoma
    Jantunen, E
    Koivunen, E
    Putkonen, M
    Siitonen, T
    Juvonen, E
    Nousiainen, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (05) : 402 - 406
  • [23] IS THERE A ROLE FOR HIGH-DOSE CHEMOTHERAPY (HDCT) WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) IN HIGH-RISK NEUROBLASTOMA IN RESOURCE-LIMITED SETTINGS?
    Radhakrishnan, Venkatraman
    Venkatakrishnan, Kritthivasan
    Kannan, Krishnarathinam
    Kalaiyarasi, Jayachandran Perumal
    Mehra, Nikita
    Karunakaran, Parathan
    Selvarajan, Gangothri
    Kesana, Sivasree
    Indhuja, M. V.
    Rajendaran, Akhil
    Balaji, Tk
    Srinivasan, Prasanth
    Das, Gargi
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [24] FACTORS IMPACTING TIME TO ENGRAFTMENT IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT
    Hillier, Kirsty
    Foster, Jennifer
    Cheng, W.
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [25] Stem cell reserve following autologous hematopoietic stem cell transplantation
    Mayer, F
    Kanz, L
    INTERNIST, 1999, 40 (03): : 323 - 325
  • [26] Autologous stem cell transplantation following high-dose chemotherapy in children with high-risk neuroblastoma: Practicality in resource-limited countries
    Lau, Sie Chong Doris
    Unni, Mohamed Najib Mohamed
    Teh, Kok Hoi
    Aziz, Mimi Azura
    Muda, Zulaiha
    Thomas, Shoba Anne
    Quah, Shiao Wei
    Ibrahim, Hishamshah
    Othman, Ida Shahnaz
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [27] Factors impacting time to engraftment in patients with high-risk neuroblastoma following autologous stem cell transplant
    Hillier, Kirsty
    Krance, Robert
    Foster, Jennifer Haunani
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant
    Hillier, Kirsty
    Cheng, W. Susan
    Whittle, Sarah B.
    Krance, Robert
    Foster, Jennifer H.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (07) : E569 - E574
  • [29] Vitiligo Following Autologous Hematopoietic Stem Cell Transplantation
    Nguyen, James
    Singh, Navdeep
    Afifi, Salma
    Giralt, Sergio
    Lacouture, Mario E.
    Busam, Klaus J.
    Hassoun, Hani
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : E171 - E173
  • [30] ENTEROCOCCUS SPP CONTAMINATED AUTOLOGOUS STEM CELL TRANSPLANTATION IN HIGH RISK NEUROBLASTOMA
    Minasyan, Elya
    Soghomonyan, Diana
    Papyan, Ruzanna
    Avagyan, Anna
    Petrosyan, Mery
    Pepanyan, Armine
    Gizhlaryan, Mane
    Shamilyan, Andranik
    Danielyan, Samvel
    Sargsyan, Lilit
    Meliksetyan, Karen
    Tamamyan, Gevorg
    Krmoyan, Lusine
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S593 - S594
12345